Profile
HealthCap is a venture capital firm based in Stockholm, specializing in life sciences. Founded in 1996, the firm boasts a diverse team with expertise in medicine, finance, and biochemistry. HealthCap has distinguished itself by focusing on investments that challenge current medical paradigms to develop breakthrough therapies with the potential to cure diseases and enhance quality of life. The firm has contributed significantly to the life science ecosystem worldwide by fostering innovation and emphasizing impact and sustainability.
HealthCap invests in a variety of sectors within life sciences, targeting high unmet medical needs and emerging therapeutics, particularly in rare diseases, cancers, and genetic disorders. The firm has funded over 130 companies, facilitating 48 IPOs on 14 markets and achieving approvals for 34 pharmaceutical products. HealthCap primarily backs companies that develop therapeutic interventions to improve patient outcomes, embracing precision medicine as a fundamental strategy. The firm's commitment to collaboration with various stakeholders is integral to its responsible investment strategy.
Notable investments in HealthCap’s portfolio include Spruce Biosciences - focuses on rare endocrine disorders, Aprea Therapeutics - oncology therapeutics, and other companies aimed at developing therapies for life-threatening conditions. The firm has played an active role in helping portfolio companies achieve significant growth, often preparing them for public offerings or trade sales.
Industry
Contacts
Instant access on the web. Plans from $129/month — see pricing.